Brawn Laboratories Limited Warfarin Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Warfarin Export Records India — #13 Exporter, 10 Shipments, $29.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Warfarin

India Pharmaceutical Trade Intelligence

$7.4M135 Suppliers72 CountriesHS 30049099

ExportsIndia → UNITED STATES38.6%India → SOUTH AFRICA25.3%

ImportsUNITED KINGDOM → India$1.4K UNITED STATES → India$420

#1 Supplier: AMNEAL PHARMACEUTICALS #1 Buyer: AMNEAL PHARMACEUTICALS,

Brawn Laboratories Limited — Warfarin Exporter #13 | $29.7K Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Warfarin Exporter Profile

Indian Pharmaceutical Exporter · #13 for Warfarin · $29.7K export value · DGFT Verified

Brawn Laboratories Limited is the #13 Indian exporter of Warfarin with $29.7K in export value and 10 verified shipments. Brawn Laboratories Limited holds a 0.4% market share in Warfarin exports across 2 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Warfarin Export Profile: Buyers & Destinations

Brawn Laboratories Limited Warfarin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Warfarin?

Country	Value	Shipments	Share
UNITED STATES	$2.9M	245	43.1%
SOUTH AFRICA	$1.9M	76	28.3%
PHILIPPINES	$424.4K	12	6.4%
UNITED KINGDOM	$277.7K	28

Who Are the Top Buyers of Warfarin from India?

Buyer	Country	Value	Orders
AMNEAL PHARMACEUTICALS, LLC (KY)	UNITED STATES	$1.5M	158
AMNEAL PHARMACEUTICALS LLC KY	UNITED STATES	$893.4K	56
MEDPRO PHARMACEUTICA PTY LIMITED	SOUTH AFRICA	$508.5K	18
STRIDES SOUTH AFRICA PTY LTD	SOUTH AFRICA	$477.9K	15
AJANTA PHARMA PHILIPPINES INC	PHILIPPINES	$374.2K	11
AMNEAL PHARMACEUTICALS LLC	UNITED STATES	$343.1K	16
MEDPRO PHARMACEUTICA PTY LTD	SOUTH AFRICA	$264.0K	9
MEDPRO PHARMACEUTICA (PTY) LTD,	SOUTH AFRICA	$251.0K	10
PHARMACARE DRUG STORE	JORDAN	$209.5K	9
STRIDES PHARMA UK LTD	UNITED KINGDOM	$170.9K	12

India's Warfarin is purchased by 218 buyers worldwide. The top buyer is AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES), followed by AMNEAL PHARMACEUTICALS LLC KY and MEDPRO PHARMACEUTICA PTY LIMITED.

How Does Brawn Laboratories Limited Compare to Nearest Warfarin Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	IPCA LABORATORIES LIMITED	$55.6K	7	2	$7.9K
12	UNICURE REMEDIES PRIVATE LIMITED	$45.5K	6	2	$7.6K
13	BRAWN LABORATORIES LIMITED ★	$29.7K	10	2	$3.0K

Brawn Laboratories Limited ranks #13 among 135 Indian Warfarin exporters. Average shipment value of $3.0K compared to the market average of $49.9K. The closest competitors by value are IPCA LABORATORIES LIMITED and UNICURE REMEDIES PRIVATE LIMITED.

Which Indian Ports Ship Warfarin Exports?

Port	Shipments	% Share
SAHAR AIR	198	14.9%
SAHAR AIR CARGO ACC (INBOM4)	168	12.6%
DELHI AIR CARGO ACC (INDEL4)	158	11.9%
DELHI AIR	121	9.1%
MUNDRA SEA	118	8.9%
MUNDRA SEA (INMUN1)	81	6.1%
Bombay Air	68	5.1%
NHAVA SHEVA SEA (INNSA1)	55	4.1%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Warfarin Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Warfarin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 72+ countries, 218+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Warfarin

Warfarin

Brawn Laboratories Limited — Warfarin Exporter Profile

Brawn Laboratories Limited — Warfarin Export Profile: Buyers & Destinations

Where Does India Export Warfarin?

Who Are the Top Buyers of Warfarin from India?

What Is India's Total Warfarin Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Warfarin Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Warfarin Exporters?

Regulatory Requirements: Exporting Warfarin to Key Markets

United States — FDA

South Africa — SAHPRA

How Does Brawn Laboratories Limited Compare to Nearest Warfarin Exporters?

Which Indian Ports Ship Warfarin Exports?

What Other Cardiovascular Products Does Brawn Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Warfarin Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Warfarin Export Data from Brawn Laboratories Limited

Warfarin Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source